Several SARS-CoV-2 vaccine candidates are currently in the pipeline. In this context and with the aim of informing SARS-CoV-2 vaccine development, licensure, decision-making, and implementation, Dr. Ghina Mumtaz and Sarah Al-Omari from the Faculty of Health Sciences at the American University of Beirut along with experts from Cornell University and Qatar University published a new study entitled "Epidemiological impact of SARS-CoV-2 vaccination: mathematical modeling analyses."
Through determining key preferred vaccine product characteristics and associated population-level impact, the study suggests that even a partially-efficacious vaccine can offer a fundamental solution to control
SARS-CoV-2 infection and at high cost-effectiveness.
Read the full study HERE